Exit Glenmark Pharma, says Rajat Bose

Rajat Bose of rajatkbose.com told CNBC-TV18, "The earlier phase of Glenmark Pharma when it was moving almost like Sun Pharma. That phase is over and after that there had been a major medium-term correction and now the stock is mostly sideways rangebound and especially in a sector like pharma where you would get to hear FDA issues and all that and then it will go up or down as the case maybe depending on the situation."

"My suggestion is that you better exit this and get into a sector which is showing good growth, maybe realty or infrastructure or aviation, wherever you like but pharma – it is kind of rock-n-roll music every day. So I would prefer to avoid that and select some other sector," he added.